Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 15 12 2021
revised: 16 04 2022
accepted: 04 05 2022
pubmed: 10 5 2022
medline: 9 6 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

Coronary spasm has been suggested to be the underlying mechanism of chest pain in patients with myocarditis and unobstructed coronary arteries. Here we sought to investigate a potential association between virus type and coronary spasm endotype in patients with biopsy-proven viral myocarditis. A total of 618 consecutive patients with unobstructed coronary arteries who underwent endomyocardial biopsy between 2008 and 2018 were screened. Viral myocarditis defined as (immuno-)histological evidence of myocardial inflammation and proof of viral genome by PCR was confirmed in 114 patients. Of these, 34 patients had undergone additional intracoronary acetylcholine (ACh) testing and served as the final study cohort. Patients in this study were 51 ± 27 years old, 41% were female and mean left ventricular ejection fraction was 58 ± 23%. Most frequently, virus DNA was detected by PCR from parvovirus B19 (PVB19, 59%) and human herpesvirus 6 (HHV6, 26%). ACh testing revealed epicardial spasm in 10 patients (29%) and microvascular spasm in 11 patients (32%). The rate of coronary spasm was higher in patients with PVB19-associated myocarditis compared to those with HHV6-associated myocarditis (80% vs. 33%, p = 0.031). In particular, there was a higher prevalence of microvascular spasm in patients with PVB19 compared to HHV6 infection (45% vs. 0%, p = 0.018). Coronary spasm is a frequent finding in patients with biopsy-proven viral myocarditis supporting the hypothesis that coronary spasm may contribute to chest pain in these patients. We observed a particular association of microvascular spasm with PVB19 infection.

Sections du résumé

BACKGROUND
Coronary spasm has been suggested to be the underlying mechanism of chest pain in patients with myocarditis and unobstructed coronary arteries. Here we sought to investigate a potential association between virus type and coronary spasm endotype in patients with biopsy-proven viral myocarditis.
METHODS
A total of 618 consecutive patients with unobstructed coronary arteries who underwent endomyocardial biopsy between 2008 and 2018 were screened. Viral myocarditis defined as (immuno-)histological evidence of myocardial inflammation and proof of viral genome by PCR was confirmed in 114 patients. Of these, 34 patients had undergone additional intracoronary acetylcholine (ACh) testing and served as the final study cohort.
RESULTS
Patients in this study were 51 ± 27 years old, 41% were female and mean left ventricular ejection fraction was 58 ± 23%. Most frequently, virus DNA was detected by PCR from parvovirus B19 (PVB19, 59%) and human herpesvirus 6 (HHV6, 26%). ACh testing revealed epicardial spasm in 10 patients (29%) and microvascular spasm in 11 patients (32%). The rate of coronary spasm was higher in patients with PVB19-associated myocarditis compared to those with HHV6-associated myocarditis (80% vs. 33%, p = 0.031). In particular, there was a higher prevalence of microvascular spasm in patients with PVB19 compared to HHV6 infection (45% vs. 0%, p = 0.018).
CONCLUSION
Coronary spasm is a frequent finding in patients with biopsy-proven viral myocarditis supporting the hypothesis that coronary spasm may contribute to chest pain in these patients. We observed a particular association of microvascular spasm with PVB19 infection.

Identifiants

pubmed: 35533750
pii: S0167-5273(22)00659-3
doi: 10.1016/j.ijcard.2022.05.008
pii:
doi:

Substances chimiques

Acetylcholine N9YNS0M02X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Andreas Seitz (A)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany. Electronic address: andreas.seitz@rbk.de.

Valeria Martínez Pereyra (V)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany.

Astrid Hubert (A)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany.

Karin Klingel (K)

University of Tübingen, Cardiopathology, Institute for Pathology and Neuropathology, Germany.

Raffi Bekeredjian (R)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany.

Udo Sechtem (U)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany.

Peter Ong (P)

Robert-Bosch-Krankenhaus, Department of Cardiology and Angiology, 70376 Stuttgart, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH